Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
van den eeckhout e[au]
(47 results)?
Interleukin-1 as Innate Mediator of T Cell Immunity.
Front Immunol. 2021 Jan 27;11:621931. doi: 10.3389/fimmu.2020.621931. eCollection 2020.
Front Immunol. 2021.
PMID: 33584721
Free PMC article.
Review.
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state.
Van Lint S, Van Parys A, Van Den Eeckhout B, Vandamme N, Plaisance S, Verhee A, Catteeuw D, Rogge E, De Geest J, Vanderroost N, Roels J, Saeys Y, Uzé G, Kley N, Cauwels A, Tavernier J.
Van Lint S, et al. Among authors: van den eeckhout b.
Mol Cancer. 2023 Nov 29;22(1):191. doi: 10.1186/s12943-023-01908-6.
Mol Cancer. 2023.
PMID: 38031106
Free PMC article.
Item in Clipboard
Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE.
Cauwels A, Van Lint S, Rogge E, Verhee A, Van Den Eeckhout B, Pang S, Prinz M, Kley N, Uzé G, Tavernier J.
Cauwels A, et al. Among authors: van den eeckhout b.
Sci Rep. 2021 Nov 3;11(1):21575. doi: 10.1038/s41598-021-00891-6.
Sci Rep. 2021.
PMID: 34732771
Free PMC article.
Item in Clipboard
Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity.
Van Den Eeckhout B, Ballegeer M, De Clercq J, Burg E, Saelens X, Vandekerckhove L, Gerlo S.
Van Den Eeckhout B, et al.
Int J Mol Sci. 2023 Oct 30;24(21):15770. doi: 10.3390/ijms242115770.
Int J Mol Sci. 2023.
PMID: 37958758
Free PMC article.
Item in Clipboard
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication.
Van Den Eeckhout B, Huyghe L, Van Lint S, Burg E, Plaisance S, Peelman F, Cauwels A, Uzé G, Kley N, Gerlo S, Tavernier J.
Van Den Eeckhout B, et al.
J Immunother Cancer. 2021 Nov;9(11):e003293. doi: 10.1136/jitc-2021-003293.
J Immunother Cancer. 2021.
PMID: 34772757
Free PMC article.
Item in Clipboard
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.
Van Den Eeckhout B, Van Hoecke L, Burg E, Van Lint S, Peelman F, Kley N, Uzé G, Saelens X, Tavernier J, Gerlo S.
Van Den Eeckhout B, et al.
NPJ Vaccines. 2020 Jul 23;5(1):64. doi: 10.1038/s41541-020-00211-5. eCollection 2020.
NPJ Vaccines. 2020.
PMID: 32714571
Free PMC article.
Item in Clipboard
Cite
Cite